Cargando…

Jiyuan oridonin A induces differentiation of acute myeloid leukemia cells including leukemic stem-like cells

Acute myeloid leukemia (AML) is an aggressive form of hematological neoplasia characterized by failure of myeloid differentiation. AML is a leading cause of death from leukemia. Cytarabine chemotherapy resistance is a major source of refractory/relapsed AML. A major obstacle to the successful treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Fahui, Gao, Congying, Li, Xueming, Wang, Jiangyun, Zhao, Yao, Ke, Yu, Liu, Ying, Liu, Hong-Min, Hu, Zhenbo, Wei, Liuya, Chen, Zhe-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484275/ https://www.ncbi.nlm.nih.gov/pubmed/36133825 http://dx.doi.org/10.3389/fphar.2022.1001552

Ejemplares similares

Differentiation of imatinib -resistant chronic myeloid leukemia cells with BCR-ABL-T315I mutation induced by Jiyuan Oridonin A
por: Xu, Yun, et al.
Publicado: (2023)

Jiyuan Oridonin A Overcomes Differentiation Blockade in Acute Myeloid Leukemia Cells With MLL Rearrangements via Multiple Signaling Pathways
por: Qu, Mei, et al.
Publicado: (2021)

Histone Deacetylase Inhibitor I3 Induces the Differentiation of Acute Myeloid Leukemia Cells with t (8; 21) or MLL Gene Translocation and Leukemic Stem-Like Cells
por: Zhao, Mengjie, et al.
Publicado: (2022)

I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibition
por: Gao, Congying, et al.
Publicado: (2023)

OGP46 Induces Differentiation of Acute Myeloid Leukemia Cells via Different Optimal Signaling Pathways
por: Zhao, Min, et al.
Publicado: (2021)

The Histone Deacetylase Inhibitor I13 Induces Differentiation of M2, M3 and M5 Subtypes of Acute Myeloid Leukemia Cells and Leukemic Stem-Like Cells
por: Ma, Xiangyu, et al.
Publicado: (2022)

The Histone Deacetylase Inhibitor I1 Induces Differentiation of Acute Leukemia Cells With MLL Gene Rearrangements via Epigenetic Modification
por: Yao, Jingfang, et al.
Publicado: (2022)

Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity
por: Li, Xiang, et al.
Publicado: (2021)

Oridonin Delays Aging Through the AKT Signaling Pathway
por: An, Yongpan, et al.
Publicado: (2022)

Honokiol Induces Ferroptosis by Upregulating HMOX1 in Acute Myeloid Leukemia Cells
por: Lai, Xingrong, et al.
Publicado: (2022)

Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses
por: Kadioglu, Onat, et al.
Publicado: (2018)

Leukemic stem cells and therapy resistance in acute myeloid leukemia
por: Stelmach, Patrick, et al.
Publicado: (2023)

Cannabidiol Reduces Leukemic Cell Size – But Is It Important?
por: Kalenderoglou, Nikoletta, et al.
Publicado: (2017)

Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?
por: Soverini, Simona, et al.
Publicado: (2021)

Research on sand body architecture at the intersection of a bidirectional sedimentary system in the Jiyuan area of Ordos Basin
por: Tong, Qiang, et al.
Publicado: (2023)

Leukemic stem cell phenotype is associated with mutational profile in acute myeloid leukemia
por: Han, Heejoo, et al.
Publicado: (2021)

Safety and efficacy of a modified busulfan/cyclophosphamide conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation in acute myeloid leukemia
por: Shi, Yuan-Yuan, et al.
Publicado: (2023)

Oridonin effectively reverses the drug resistance of cisplatin involving induction of cell apoptosis and inhibition of MMP expression in human acute myeloid leukemia cells
por: Zhang, Yuan, et al.
Publicado: (2017)

Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia
por: Laverdière, Isabelle, et al.
Publicado: (2018)

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
por: Depreter, Barbara, et al.
Publicado: (2020)

Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias
por: Zhai, Xingjian, et al.
Publicado: (2022)

Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells
por: Glamoclija, Una, et al.
Publicado: (2022)

Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia
por: Niu, Xiaojia, et al.
Publicado: (2021)

Influence of verapamil on the pharmacokinetics of oridonin in rats
por: Liu, Jing, et al.
Publicado: (2019)

Tightness Mechanism and Quantitative Analysis of the Pore Evolution Process of Triassic Ch-6 Tight Reservoir, Western Jiyuan Area, Ordos Basin, China
por: Li, Shutong, et al.
Publicado: (2021)

Matrine Promotes Human Myeloid Leukemia Cells Apoptosis Through Warburg Effect Mediated by Hexokinase 2
por: Lin, Guibin, et al.
Publicado: (2019)

Network pharmacology-based investigation and experimental validation of the mechanism of scutellarin in the treatment of acute myeloid leukemia
por: Huang, Zhe, et al.
Publicado: (2022)

Azelaic Acid Exerts Antileukemic Activity in Acute Myeloid Leukemia
por: Pan, Yunbao, et al.
Publicado: (2017)

P452: CD4+ T CELLS REDUCE THE POPULATION OF LEUKEMIC STEM CELLS IN ACUTE MYELOID LEUKEMIA
por: Schnüriger, Noah, et al.
Publicado: (2023)

The IGF2/IGF1R/Nanog Signaling Pathway Regulates the Proliferation of Acute Myeloid Leukemia Stem Cells
por: Xu, Dan-dan, et al.
Publicado: (2018)

Inhibitory Effects of Omacetaxine on Leukemic Stem Cells and BCR-ABL-Induced Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Mice
por: Chen, Yaoyu, et al.
Publicado: (2009)

A Novel Application of Furazolidone: Anti-Leukemic Activity in Acute Myeloid Leukemia
por: Jiang, Xueqing, et al.
Publicado: (2013)

Surface morphology of leukemic cells from chronic myeloid leukemia under atomic force microscopy
por: Gaman, Amelia, et al.
Publicado: (2013)

Leukemic Stem Cell Frequency: A Strong Biomarker for Clinical Outcome in Acute Myeloid Leukemia
por: Terwijn, Monique, et al.
Publicado: (2014)

Bullous drug eruption with leukemic cell infiltrate in the setting of new-onset acute myeloid leukemia
por: Khanna, Trisha, et al.
Publicado: (2017)

CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells
por: Touzet, Lucas, et al.
Publicado: (2019)

An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination
por: Pallarès, Victor, et al.
Publicado: (2020)

Anti-Leukemic Activity of Brassica-Derived Bioactive Compounds in HL-60 Myeloid Leukemia Cells
por: Núñez-Sánchez, María Ángeles, et al.
Publicado: (2022)

Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia
por: Parting, Oliver, et al.
Publicado: (2020)

A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges
por: Chen, Ying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3iiqu3ep4ad69em1jkg9crft1t